Sonic Healthcare USA, Inc. announced it has acquired substantially all of the assets of Cairo Diagnostics, LLC, Cairo Diagnostics NJ, LLC and Rye Management and Logistics
Norgine announced the successful completion of the acquisition of Theravia, an international pharmaceutical company specialising in therapies for patients with rare and debilitating conditions. The closure
Adobe Population Health, a company known for its innovative care management solutions, has announced the acquisition of MedZed Physician Services. This move marks Adobe’s entry
US WorldMeds reported the successful closing of the previously announced acquisition of Adaptimmune Therapeutics plc’s (Adaptimmune) cell–therapy assets—including TECELRA® (afamitresgene autoleucel), lete–cel, afami–cel, and uza–cel. The acquisition
Medical Technology Associates, LLC (MTA) is pleased to announce the acquisition of Silver Reef Biomedical Services, Inc. (Silver Reef Biomed). Silver Reef Biomed, headquartered in Las
Acquisition successfully closed for enterprise value of $5.1 billion Siemens AG announced that it has completed the acquisition of Dotmatics, a leading provider of Life Sciences R&D
Novartis announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the completion of the acquisition, shares of common stock, par value
Leading children’s mental health provider expands footprint in North Carolina, ensuring continued access to behavioral health services for families that need it most. Acute Behavioral
Bioness Medical further expands pipeline of next-generation robotics offerings for Neuro Rehab Bioness Medical, Inc. a leading neuro-rehabilitation Company aiming to improve and restore function
H.I.G. Capital, a leading global alternative investment firm with $70 billion of capital under management, is pleased to announce that one of its affiliates has completed the acquisition
Sun Pharmaceutical Industries Limited together with its subsidiaries and/or associated companies, announced the successful completion of its acquisition of Checkpoint Therapeutics, an immunotherapy and targeted
Addition of dordaviprone strengthens Jazz’s late-stage oncology pipeline and reinforces commitment to addressing rare diseases with significant unmet need Jazz Pharmaceuticals announced the successful completion
